AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 61 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $22,625,330 | +82.3% | 1,513,400 | +0.4% | 0.00% | – |
Q3 2022 | $12,410,000 | +26.0% | 1,507,955 | +0.4% | 0.00% | – |
Q2 2022 | $9,848,000 | +17.3% | 1,501,317 | 0.0% | 0.00% | – |
Q1 2022 | $8,392,000 | +22.1% | 1,501,317 | +2.5% | 0.00% | – |
Q4 2021 | $6,871,000 | -23.7% | 1,465,107 | +0.6% | 0.00% | – |
Q3 2021 | $9,000,000 | -5.7% | 1,456,230 | +0.6% | 0.00% | – |
Q2 2021 | $9,541,000 | -5.0% | 1,447,686 | +5.5% | 0.00% | – |
Q1 2021 | $10,046,000 | +39.0% | 1,372,537 | +9.6% | 0.00% | – |
Q4 2020 | $7,225,000 | +10.7% | 1,252,147 | +14.0% | 0.00% | – |
Q3 2020 | $6,524,000 | +16.8% | 1,098,349 | +1.3% | 0.00% | – |
Q2 2020 | $5,584,000 | +135.8% | 1,084,266 | +65.8% | 0.00% | – |
Q1 2020 | $2,368,000 | – | 654,008 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIGH Capital Management LLC | 1,986,176 | $12,275,000 | 2.58% |
Worth Venture Partners, LLC | 454,364 | $2,808,000 | 1.26% |
Opaleye Management Inc. | 455,600 | $2,816,000 | 0.53% |
J. Goldman & Co LP | 1,663,229 | $10,279,000 | 0.52% |
X-Square Capital, LLC | 92,283 | $570,000 | 0.30% |
NEA Management Company, LLC | 3,952,958 | $24,429,000 | 0.29% |
Birchview Capital, LP | 40,000 | $247,000 | 0.17% |
PERSONAL CFO SOLUTIONS, LLC | 23,000 | $142,000 | 0.03% |
PURA VIDA INVESTMENTS, LLC | 147,574 | $912,000 | 0.03% |
GSA CAPITAL PARTNERS LLP | 35,232 | $218,000 | 0.02% |